Related Experiment Video
Updated: May 7, 2025

Syngeneic Mouse Orthotopic Allografts to Model Pancreatic Cancer
Published on: October 4, 2022
PCAT19: the role in cancer pathogenesis and beyond
Haijun Hu1, Hongliang Luo2, Ziqing Deng3
1Department of Anesthesiology, The Second Affiliated Hospital, Jiangxi Medical College, Nanchang University, Nanchang, Jiangxi, China.
Long non-coding RNA PCAT19 shows dual roles in cancer, acting as an oncogene or tumor suppressor. Research highlights its potential as a diagnostic and prognostic biomarker for cancer and a therapeutic target for cancer and pain management.
Area of Science:
- Oncology
- Molecular Biology
- RNA Biology
Background:
- Long non-coding RNA (lncRNA) PCAT19 is implicated in various cancers.
- Abnormal PCAT19 expression correlates with clinical features and prognosis.
- PCAT19 demonstrates potential as a diagnostic and prognostic biomarker.
Purpose of the Study:
- To review the multifaceted roles of PCAT19 in cancer pathogenesis and progression.
- To explore PCAT19's molecular mechanisms and regulatory pathways.
- To assess PCAT19's potential as a therapeutic target.
Main Methods:
- Literature review and compilation of current research on PCAT19.
- Analysis of PCAT19's expression patterns in different cancer types.
- Investigation of PCAT19's involvement in cancer-related biological processes and signaling pathways.
Main Results:
- PCAT19 exhibits oncogenic or tumor-suppressive functions depending on the cancer type.
- PCAT19 influences cell proliferation, apoptosis, invasion, migration, and metabolism.
- PCAT19 acts as a competing endogenous RNA (ceRNA) or interacts with proteins to regulate key cancer pathways (e.g., MELK, p53, cell cycle).
- Emerging evidence links PCAT19 to neuropathic pain modulation.
Conclusions:
- PCAT19 is a significant player in cancer development and progression.
- PCAT19 holds promise as a biomarker for cancer diagnosis and prognosis.
- Targeting PCAT19 may offer therapeutic strategies for cancer and pain management.
Related Concept Videos
Tumor Progression
Colon cancer is one of the best-documented examples of tumor progression. Early mutation in the APC gene in colon cells causes a small growth on the colon wall called a polyp. With time, this polyp grows into a benign, pre-cancerous tumor. Further...
mTOR Signaling and Cancer Progression
The mTOR pathway or the...
Cancer-Critical Genes I: Proto-oncogenes
When the function of certain critical genes, especially those involved in cell cycle regulation and cell growth signaling cascades, gets disrupted, it upsets the cell cycle progression. Such cells with unchecked cell cycles start proliferating uncontrollably and eventually develop into tumors.
Such genes that act...
Cancer-Critical Genes II: Tumor Suppressor Genes
When the function of certain critical genes, especially those involved in cell cycle regulation and cell growth signaling cascades, gets disrupted, it upsets the cell cycle progression. Such cells with unchecked cell cycles start proliferating uncontrollably and eventually develop into tumors.
Such genes that act...
Loss of Tumor Suppressor Gene Functions
When the tumor suppressor genes develop mutations or are lost, cells start growing out of control, leading to cancer. However, a single functional copy of the tumor suppressor gene is enough for the cells to maintain their normal functions and cell...
Abnormal Proliferation

